Paroxetine Hydrochloride NDC 31722-578

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-578Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0578Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-578-25	31722057825	1 BOTTLE in 1 CARTON (31722-578-25) / 250 mL in 1 BOTTLEMarketed from Mar 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Paroxetine Hydrochloride
Generic name (nonproprietary): paroxetine hydrochloride
Active ingredients: Paroxetine hydrochloride — 10 mg/5mL
Dosage form: Suspension
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219954
Marketing start: Mar 5, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 31722-578_5092043a-0e8c-05e1-e063-6394a90ad3dcSPL ID 5092043a-0e8c-05e1-e063-6394a90ad3dcSPL set ID 26d37a39-1c53-461c-8834-c67fbffcfe99RxCUI 312242UNII X2ELS050D8UPC 0331722578257
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722057825 followed by a unit qualifier and the quantity

Package 31722-0578-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 29, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Paroxetine oral suspension is indicated in adults for the treatment of: • Major depressive disorder (MDD) • Obsessive compulsive disorder (OCD) • Panic disorder (PD) • Social anxiety disorder (SAD) • Generalized anxiety disorder (GAD) • Posttraumatic stress disorder (PTSD) Paroxetine is a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of ( 1 ): • Major Depressive Disorder (MDD) • Obsessive Compulsive Disorder (OCD) • Panic Disorder (PD) • Social Anxiety Disorder (SAD) • Generalized Anxiety Disorder (GAD) • Posttraumatic Stress Disorder (PTSD)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)